Zhou Zhike, Liang Yifan, Zhang Xiaoqian, Xu Junjie, Kang Kexin, Qu Huiling, Zhao Chuansheng, Zhao Mei
Department of Geriatrics, The First Affiliated Hospital, China Medical University, Shenyang, China.
Department of Neurology, The First Affiliated Hospital, China Medical University, Shenyang, China.
Front Neurol. 2018 Dec 20;9:1114. doi: 10.3389/fneur.2018.01114. eCollection 2018.
The aim of our meta-analysis was to evaluate the association between plasma d-dimer and intracerebral hemorrhage (ICH). Embase, Pubmed, and Web of Science were searched up to the date of March 19th, 2018, and manual searching was used to extract additional articles. Standard mean difference (SMD) with 95% confidence intervals (CI) was calculated to evaluate d-dimer levels. Thirteen studies including 891 ICH patients and 1,573 healthy controls were included. Our results revealed that higher levels of d-dimer were displayed in ICH patients than those in healthy controls (95% CI= 0.98-2.00, < 0.001). Subgroup analysis based on continent of Asia and Europe, sample size, as well as age in relation to d-dimer levels between ICH patients and healthy controls did not change the initial observation; whereas no differences of d-dimer levels were found between ICH and controls in America. This meta-analysis revealed that high level of d-dimer is associated with the risk of ICH. Plasma d-dimer is suggested to be a potential biomarker for patients with ICH in Asia and Europe rather than in America. There were no impact of sample size-related differences and age-related diversities on the risk of ICH with respect to d-dimer levels.
我们的荟萃分析旨在评估血浆D-二聚体与脑出血(ICH)之间的关联。检索了截至2018年3月19日的Embase、Pubmed和Web of Science数据库,并通过手工检索获取其他文章。计算95%置信区间(CI)的标准平均差(SMD)以评估D-二聚体水平。纳入了13项研究,包括891例ICH患者和1573例健康对照。我们的结果显示,ICH患者的D-二聚体水平高于健康对照(95%CI = 0.98 - 2.00,P < 0.001)。基于亚洲和欧洲大陆、样本量以及ICH患者与健康对照之间D-二聚体水平相关年龄的亚组分析并未改变初始观察结果;而在美国,ICH患者与对照之间未发现D-二聚体水平存在差异。这项荟萃分析表明,高水平的D-二聚体与ICH风险相关。血浆D-二聚体被认为是亚洲和欧洲而非美国ICH患者的潜在生物标志物。样本量相关差异和年龄相关差异对D-二聚体水平方面的ICH风险没有影响。